volume 40, issue 25, P2070-2085 2018
DOI: 10.1093/eurheartj/ehy377
View full text
Has erratum
|
|
Share

Abstract: Non-adherence has been well recognized for years to be a common issue that significantly impacts clinical outcomes and health care costs. Medication adherence is remarkably low even in the controlled environment of clinical trials where it has potentially complex major implications. Collection of non-adherence data diverge markedly among cardiovascular randomized trials and, even where collected, is rarely incorporated in the statistical analysis to test the consistency of the primary endpoint(s). The imprecis…

expand abstract
editorial notices